Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hillman Solutions Corp.HLMN · Entity 4721 | CFO and Treasurer | September 11, 2026 | September 14, 2026 |
| Medpace Holdings, Inc.MEDP · Entity 3327 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hillman Solutions Corp.
Report date September 11, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 697,090 |
Reported balance
After 2026-09-11 transaction · row 1
1 source rowRow 1 · 2026-09-11 · Purchase · Acquired 35,500 · Balance 697,090 F1: This transaction was executed in multiple trades at prices ranging from $6.915 to $7.085, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $6.915 to $7.085, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Medpace Holdings, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 987 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Exercise / conversion · Acquired 32 · Balance 987 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 32 |
Reported balance
After 2026-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-30 · Exercise / conversion · Disposed 32 · Balance 32 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
F2: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date April 03, 2017 · Filed April 04, 2017
Section 16 reporting ended · disclosed 2017-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 92,360 |
Reported balance
After 2017-04-03 transaction · row 1
1 source rowRow 1 · 2017-04-03 · Grant · Acquired 5,124 · Balance 92,360 F1: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 40,071 |
Reported balance
After 2017-04-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-04-03 · Grant · Acquired 40,071 · Balance 40,071 F2: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 23,301 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,301 F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.40 · Expires 2025-08-31 | Direct | 55,020 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 55,020 F4: Option becomes exercisable in three equal annual installments, commencing 8/31/2018. |
| Common StockSEC Table I · non-derivative | Direct | 9,966.1892 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,966.1892 |
| Common Stock (pep)SEC Table I · non-derivative | Direct | 5,661.1892 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,661.1892 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.
F2: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.
F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option becomes exercisable in three equal annual installments, commencing 8/31/2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 32 | $0.00 | $0.00 |
DisclosureSEC source: 0001558592-26-000014 · wk-form4_1790975728.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32 Underlying: Common Stock · 32 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 01:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 32 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001558592-26-000014 · wk-form4_1790975728.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| September 11, 2026 Filed Sep 14, 2026 12:49 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | PurchaseCommon Stock | 35,500 | $7.00 | $248,500.00 |
DisclosureSEC source: 0001558592-26-000012 · wk-form4_1789390184.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 697,090 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.915 to $7.085, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 20:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,858 | $0.00 Strike: $84.36 | $0.00 |
DisclosureSEC source: 0001558592-26-000010 · wk-form4_1787949166.xml · derivative · entry 3 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,858 shares Expires 2027-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 13, 2021. Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 20:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,858 | $617.81 | $2,383,510.98 |
DisclosureSEC source: 0001558592-26-000010 · wk-form4_1787949166.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $617.73 to $618.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 20:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,858 | $84.36 | $325,460.88 |
DisclosureSEC source: 0001558592-26-000010 · wk-form4_1787949166.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001558592-26-000008 · wk-form4_1783022884.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 33 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001558592-26-000008 · wk-form4_1783022884.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 15, 2026 Filed May 18, 2026 21:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,110 | $0.00 Strike: $415.27 | $0.00 |
DisclosureSEC source: 0001558592-26-000006 · wk-form4_1779139104.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,110 Underlying: Common Stock · 1,110 shares Expires 2033-05-15 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001558592-26-000004 · wk-form4_1775162529.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 33 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001558592-26-000004 · wk-form4_1775162529.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 13:29 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | Tax withholdingCommon Stock | 4,038 | $8.14 | $32,869.32 |
DisclosureSEC source: 0001822492-26-000036 · wk-form4_1773149352.xml · nonDerivative · entry 3 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 661,590 Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 13:29 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | Tax withholdingCommon Stock | 13,192 | $8.14 | $107,382.88 |
DisclosureSEC source: 0001822492-26-000036 · wk-form4_1773149352.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 665,628 Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 13:29 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantCommon Stock | 46,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001822492-26-000036 · wk-form4_1773149352.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 678,820 F1 · security: Represents restricted stock units ("RSUs") that are a contingent right for the Reporting Person to receive one share of common stock for each RSU upon vesting. The RSUs will vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001558592-26-000002 · wk-form4_1767647871.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 56 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001558592-26-000002 · wk-form4_1767647871.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 21:35 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 130 | $592.46 | $77,019.80 |
DisclosureSEC source: 0001558592-25-000008 · wk-form4_1764711312.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130 Underlying: Common Stock · 130 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 22:02 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,472 | $0.00 Strike: $54.99 | $0.00 |
DisclosureSEC source: 0001558592-25-000006 · wk-form4_1763503345.xml · derivative · entry 3 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,472 shares Expires 2026-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 14, 2020. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 22:02 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 6,472 | $591.85 | $3,830,453.20 |
DisclosureSEC source: 0001558592-25-000006 · wk-form4_1763503345.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 833 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $588.98 to $596.543. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 22:02 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 6,472 | $54.99 | $355,895.28 |
DisclosureSEC source: 0001558592-25-000006 · wk-form4_1763503345.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:26 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001558592-25-000004 · wk-form4_1759436767.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56 Underlying: Common Stock · 57 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:26 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 57 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001558592-25-000004 · wk-form4_1759436767.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000077 · wk-form4_1751487494.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113 Underlying: Common Stock · 57 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 57 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000077 · wk-form4_1751487494.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,224 | $0.00 Strike: $305.66 | $0.00 |
DisclosureSEC source: 0001668397-25-000069 · wk-form4_1747773901.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,224 Underlying: Common Stock · 1,224 shares Expires 2032-05-16 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 01, 2025 Filed May 5, 2025 12:28 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | PurchaseCommon Stock | 140,000 | $7.09 | $992,600.00 |
DisclosureSEC source: 0001822492-25-000097 · wk-form4_1746448095.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 632,752 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.995 to $7.185, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:35 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000048 · wk-form4_1743629740.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170 Underlying: Common Stock · 57 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: On November 29, 2024, the Reporting Person was granted 227 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:35 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 57 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000048 · wk-form4_1743629740.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 14:00 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantCommon Stock | 39,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001822492-25-000067 · wk-form4_1741701607.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,752 F1 · security: Represents restricted stock units ("RSUs") that are a contingent right for the Reporting Person to receive one share of common stock for each RSU upon vesting. The RSUs will vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2025 Filed Jan 14, 2025 16:53 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | Tax withholdingCommon Stock | 10,410 | $9.29 | $96,708.90 |
DisclosureSEC source: 0001822492-25-000025 · wk-form4_1736873575.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,485 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:36 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000004 · wk-form4_1735940180.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:36 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000004 · wk-form4_1735940180.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 662 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 227 | $340.63 | $77,323.01 |
DisclosureSEC source: 0001668397-24-000174 · wk-form4_1733261284.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227 Underlying: Common Stock · 227 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:35 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000159 · wk-form4_1727901296.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71 Underlying: Common Stock · 71 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:35 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000159 · wk-form4_1727901296.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| September 07, 2024 Filed Sep 9, 2024 15:26 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantCommon Stock | 157,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001822492-24-000145 · wk-form4_1725895564.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,895 F1 · price: Represents restricted stock units ("RSUs") that are a contingent right for the Reporting Person to receive one share of common stock for each RSU upon vesting. The RSUs will vest 50% on the third anniversary of the grant date, 25% on the fourth anniversary of the grant date, and 25% on the fifth anniversary of the grant date, in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,774 | $0.00 Strike: $42.62 | $0.00 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · derivative · entry 6 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,774 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in full on May 16, 2019. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,774 | $390.73 | $1,474,615.02 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 4 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,774 | $42.62 | $160,847.88 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 3 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,353 | $0.00 Strike: $42.62 | $0.00 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · derivative · entry 5 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,774 Underlying: Common Stock · 4,353 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in full on May 16, 2019. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 4,353 | $390.73 | $1,700,847.69 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.055. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,353 | $42.62 | $185,524.86 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000127 · wk-form4_1719951114.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142 Underlying: Common Stock · 72 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 72 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000127 · wk-form4_1719951114.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 953 | $0.00 Strike: $393.30 | $0.00 |
DisclosureSEC source: 0001668397-24-000109 · wk-form4_1716324034.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 953 Underlying: Common Stock · 953 shares Expires 2031-05-17 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 22:02 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000076 · wk-form4_1712095319.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214 Underlying: Common Stock · 72 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 22:02 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 72 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000076 · wk-form4_1712095319.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:36 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantStock Options · Derivative | 82,464 | $0.00 Strike: $9.83 | $0.00 |
DisclosureSEC source: 0001822492-24-000050 · wk-form4_1710174972.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,464 Underlying: Common Stock · 82,464 shares Expires 2034-03-07 F2 · derivative.exercise_date: Represents the grant of stock options to purchase Issuer common stock. The stock options vest in four equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:36 UTC | Hillman Solutions Corp. HLMN · Entity 4721 | GrantCommon Stock | 38,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001822492-24-000050 · wk-form4_1710174972.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,001 F1 · security: Represents restricted stock units ("RSUs") that are a contingent right for the Reporting Person to receive one share of common stock for each RSU upon vesting. The RSUs will vest on the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer through the vesting date. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionRestricted Stock Unit · Derivative | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0000892251-24-000012 · form4.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023. F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.